Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dae-Hee Kim

Showing results (351-360 of 375) with videos related to

Pageof 38
Sort By:
Heart (British Cardiac Society)|February 3, 2022
Inter-racial differences in patients undergoing transcatheter aortic valve implantationDo-Yoon Kang, Jung-Min Ahn, Juyong Brian Kim, et al.
JACC. Cardiovascular Interventions|November 28, 2021
Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve ReplacementHanbit Park, Jung-Min Ahn, Do-Yoon Kang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.
Clinical Therapeutics|February 11, 2026
Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical TrialSang Hyun Lee, Kyungil Park, Ki Hong Lee, et al.
Korean Circulation Journal|November 22, 2012
Transcatheter aortic valve implantation: early experience in KoreaWon-Jang Kim, Young-Hak Kim, Jong-Young Lee, et al.
Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.
Journal of Cardiovascular Ultrasound|October 9, 2015
Normal Echocardiographic Measurements in a Korean Population Study: Part I. Cardiac Chamber and Great Artery EvaluationJin-Oh Choi, Mi-Seung Shin, Mi-Jeong Kim, et al.
Journal of Cardiovascular Ultrasound|July 1, 2016
Normal Echocardiographic Measurements in a Korean Population Study: Part II. Doppler and Tissue Doppler ImagingJin-Oh Choi, Mi-Seung Shin, Mi-Jeong Kim, et al.
BMJ Open|January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacementHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
The American Journal of Cardiology|July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR TrialJeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Pageof 38

Showing results (351-360 of 375) with videos related to

Sort By:
Pageof 38
Heart (British Cardiac Society)|February 3, 2022
Inter-racial differences in patients undergoing transcatheter aortic valve implantationDo-Yoon Kang, Jung-Min Ahn, Juyong Brian Kim, et al.
JACC. Cardiovascular Interventions|November 28, 2021
Racial Differences in the Incidence and Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve ReplacementHanbit Park, Jung-Min Ahn, Do-Yoon Kang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.
Clinical Therapeutics|February 11, 2026
Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical TrialSang Hyun Lee, Kyungil Park, Ki Hong Lee, et al.
Korean Circulation Journal|November 22, 2012
Transcatheter aortic valve implantation: early experience in KoreaWon-Jang Kim, Young-Hak Kim, Jong-Young Lee, et al.
Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.
Journal of Cardiovascular Ultrasound|October 9, 2015
Normal Echocardiographic Measurements in a Korean Population Study: Part I. Cardiac Chamber and Great Artery EvaluationJin-Oh Choi, Mi-Seung Shin, Mi-Jeong Kim, et al.
Journal of Cardiovascular Ultrasound|July 1, 2016
Normal Echocardiographic Measurements in a Korean Population Study: Part II. Doppler and Tissue Doppler ImagingJin-Oh Choi, Mi-Seung Shin, Mi-Jeong Kim, et al.
BMJ Open|January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacementHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
The American Journal of Cardiology|July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR TrialJeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Pageof 38